<DOC>
	<DOC>NCT00261365</DOC>
	<brief_summary>The purpose of this study is to identify candidate markers predictive of response and/or serious toxicity to BMS-734016 (MDX-010).</brief_summary>
	<brief_title>Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Histologic or cytologic diagnosis of unresectable State III or IV malignant melanoma (excluding ocular melanoma); A pre and posttreatment fresh core or excision tumor biopsy must be provided.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>